KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $4.1 billion.

  • Cme Group's Interest & Investment Income rose 50.83% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year increase of 16.04%. This contributed to the annual value of $4.1 billion for FY2024, which is 22.68% down from last year.
  • Latest data reveals that Cme Group reported Interest & Investment Income of $4.1 billion as of FY2024, which was down 22.68% from $5.3 billion recorded in FY2023.
  • Cme Group's Interest & Investment Income's 5-year high stood at $5.3 billion during FY2023, with a 5-year trough of $182.7 million in FY2020.
  • For the 3-year period, Cme Group's Interest & Investment Income averaged around $3.9 billion, with its median value being $4.1 billion (2024).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 71.36% in 2020, then soared by 616.32% in 2022.
  • Cme Group's Interest & Investment Income (Yearly) stood at $182.7 million in 2020, then surged by 67.98% to $306.9 million in 2021, then surged by 616.32% to $2.2 billion in 2022, then soared by 139.96% to $5.3 billion in 2023, then declined by 22.68% to $4.1 billion in 2024.